Search PubMed⌕ Search

Biomedical subjects

M Aubry

Publications and source records attributed to M Aubry.

At least 55 records · Page 3Linked to original sources

Biosynthesis of a putative gonadotropin receptor component by rat leydig cells: isolation of a radiolabeled acidic protein of 79,000 molecular weight by affinity chromatography.

The Leydig cells of the testis are known to possess high affinity receptors for luteinizing hormone and human chorionic gonadotropin (hCG), but no information concerning the synthesis of these receptors is available yet. In order to investigate this question, we have purified crude rat interstitial cell preparations on discontinuous Percoll gradients, and Leydig cells recovered from fractions demonstrating maximum testosterone production and hCG binding capacity were incubated for 17 h in a culture medium containing [35S]methionine. Radioactive proteins solubilized with Triton X-100 were submitted to affinity chromatography on a resin consisting of hCG covalently linked to agarose. Proteins bound to the column were analyzed by two-dimensional gel electrophoresis. Autoradiography of the gel revealed a major protein (molecular weight: 79,000; pI 4.5) whose binding to the resin could be greatly diminished by an excess of hCG. The electrophoretic properties of this protein are similar to those of previously isolated gonadotropin receptor components.

Animals↗

Kinetics of the inactivation of human and bovine trypsins and chymotrypsins by alpha1-proteinase inhibitor and of their reactivation by alpha2-macroglobulin.

The time dependency of inactivation of human cationic trypsin and chymotrypsin II and of bovine trypsin and alpha-chymotrypsin by human serum has been investigated. Since the molar concentration of serum alpha1-proteinase inhibitor is much higher than that of other inhibitors, this time dependence could be used to calculate the rate constants kass for the association of alpha1-proteinase inhibitor with the four proteases. The association process was found to be second order, with kass ranging from 1 x10(4) s-1 (human trypsin) to 2.6 x 10(6) s-1 (bovine chymotrypsin). The human proteases react much more slowly with human alpha1-proteinase inhibitor than the bovine ones. But, whatever the species, chymotrypsin is inhibited more quickly than trypsin. Addition of alpha2-macroblobulin to the inactive complexes resulted in a time-dependent regeneration of enzymic activity due to the formation of alpha2-macroglobulin-protease complexes. The reactivation (i.e. dissociation) process was first order and extremely slow: the half-life of the alpha1-proteinase inhibitor-proteinase complexes ranged from 8 days (bovine chymotrypsin) to 9 months (human chymotrypsin). The human proteases formed the most stable complexes with alpha1-proteinase inhibitor. The pathological implications of these findings are discussed.

Animals↗

A kinetic study of the inhibition of human and bovine trypsins and chymotrypsins by the inter-alpha-inhibitor from human plasma.

Human plasma inter-alpha-inhibitor forms 1:1 inactive complexes with human and bovine trypsins (EC 3.4.21.4) and chymotrypsins (EC 3.4.21.1). The association and dissociation rate constants as well as the equilibrium dissociation constants (Ki) of the complexes formed of inter-alpha-inhibitor and the four proteases have been measured. The most stable complexes are those formed with the bovine enzymes. For instance, Ki = 2.1-10-11 M for bovine trypsin whereas Ki = 1.2 - 10-8 M for human trypsin. Whatever the species, the complexes formed with the chymotrypsins are less stable than those formed with the trypsins.

Animals↗

LSD: no teratogenic action in rats, mice, and hamsters.

Lysergic acid diethylamide tartrate was given to 98 pregnant rats, 67 mice, and 22 hamsters as a single dose of 5 to 500 micrograms per kilogram of body weight per day either at the beginning of gestation or during the period of organogenesis. Examination of the 1003 rat fetuses, 521 mouse fetuses, and 189 hamster fetuses obtained failed to prove any abortifacient, teratogenic, or growth-depressing effects.

Abnormalities, Drug-Induced↗